<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02867644</url>
  </required_header>
  <id_info>
    <org_study_id>2016-A00232-49</org_study_id>
    <nct_id>NCT02867644</nct_id>
  </id_info>
  <brief_title>Conversational Hypnosis in Women Undergoing Imaging for Breast Cancer</brief_title>
  <acronym>HYCOREMA</acronym>
  <official_title>Randomized Trial Comparing the Contribution of Conversational Hypnosis Versus Standard Care on Patient Anxiety During a Preoperative Breast Tracking</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut de Cancérologie de Lorraine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut de Cancérologie de Lorraine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hypothesis is to assess the contribution of conversational hypnosis on anxiety of&#xD;
      patients who undergoing for a preoperative breast tracking and improve their care&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Results not achievable after interim analysis conclusions and recruting difficulty&#xD;
  </why_stopped>
  <start_date type="Actual">November 17, 2016</start_date>
  <completion_date type="Actual">October 16, 2020</completion_date>
  <primary_completion_date type="Actual">October 16, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compare anxiety of patients undergoing for a preoperative breast marking under ultrasound according two different procedures (standard care versus standard care with conversational hypnosis)</measure>
    <time_frame>Day 1</time_frame>
    <description>The anxiety level will be assessed in each group by a visual analog scale from 0 to 10.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Compare the pain felt by patients during a preoperative breast marking under ultrasound according two different procedures (standard care versus standard care with conversational hypnosis)</measure>
    <time_frame>Day 1</time_frame>
    <description>The pain level will be assessed in each group by a visual analog scale from 0 to 10.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare the manipulator's satisfaction during a preoperative breast marking under ultrasound according two different procedures (standard care versus standard care with conversational hypnosis)</measure>
    <time_frame>Day 1</time_frame>
    <description>The manipulator's satisfaction will be assessed in each group by a numeric scale from 0 to 10.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate the receptivity of women to conversational hypnosis</measure>
    <time_frame>Day 1</time_frame>
    <description>assessment realisation time flet by patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assess the impact of conversational hypnosis on completion of the examination</measure>
    <time_frame>Day 1</time_frame>
    <description>The assessment will be evaluated in each group by the radiologist according to a visual analog scale from 0 to 10.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">171</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>standard care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>standard care+conversational hypnosis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>standard care</intervention_name>
    <description>Patients coming for preoperative breast assessment will have standard care.</description>
    <arm_group_label>standard care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>standard care + conversational hypnosis</intervention_name>
    <description>Patients coming for preoperative breast assessment will have standard care with conversational hypnosis</description>
    <arm_group_label>standard care+conversational hypnosis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients ≥ 18 years old&#xD;
&#xD;
          -  Eastern Cooperative Oncology Group (ECOG) performance status ≤ 2&#xD;
&#xD;
          -  Patient undergoing for a preoperative breast assessment&#xD;
&#xD;
          -  Patient must be affiliated to a social security system&#xD;
&#xD;
          -  Ability to provide an informed written consent form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients diagnosed with major hearing loss&#xD;
&#xD;
          -  Patients with schizophrenia&#xD;
&#xD;
          -  Patients do not understand the French language&#xD;
&#xD;
          -  Pregnant or breast feeding females&#xD;
&#xD;
          -  Refusal of the patient to participate in the study&#xD;
&#xD;
          -  Persons deprived of liberty or under supervision&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>HENROT Philippe, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut de Cancérologie de Lorraine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CH Bastia</name>
      <address>
        <city>Bastia</city>
        <zip>20600</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chu Bordeaux-Pellegrin</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU de Brest</name>
      <address>
        <city>Brest</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Léon Bérard</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>APHM La Timone</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Paul Strauss</name>
      <address>
        <city>Strasbourg</city>
        <zip>67065</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut de Cancerologie de Lorraine</name>
      <address>
        <city>Vandoeuvre Les Nancy</city>
        <zip>54519</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 11, 2016</study_first_submitted>
  <study_first_submitted_qc>August 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 16, 2016</study_first_posted>
  <last_update_submitted>September 28, 2021</last_update_submitted>
  <last_update_submitted_qc>September 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>conversational hypnosis</keyword>
  <keyword>imaging</keyword>
  <keyword>care</keyword>
  <keyword>breast neoplasia</keyword>
  <keyword>anxiety</keyword>
  <keyword>pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

